Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis

Scandinavian Journal of Immunology

Volumn 55, Issue 1, 2002, Pages 70-81

  Abdul Majid, K B ^a   Stefferl, A ^b   Bourquin, C ^c   Lassmann, H ^b   Linington, C ^c   Olsson, T ^a   Kleinau, S ^d   Harris, R A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE PREDISPOSITION; HUMORAL IMMUNITY; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIBODIES; AUTOIMMUNITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; PHAGOCYTOSIS; RECEPTORS, IGG; SPINAL CORD;

EID: 0036119318     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01024.x     Document Type: Article

References (66)

1. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
2. Bone marrow derived elements and resident microglia in brain inflammation
3. A novel myelinassociated glycoprotein defined by a mouse monoclonal antibody
4. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
5. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
6. MHC haplotypedependent regulation of MOG-induced EAE in rats
7. Screening of several H-2 congenic mouse strains identified H-2 (q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement
8. Fc receptors
9. Signal transduction by Fc receptors: The Fc epsilon RI case
10. Molecular basis of Fc receptor function
11. The IgG Fc receptor family
12. FcR gamma chain deletion results in pleiotrophic effector cell defects
13. Fcgamma receptormediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
14. The high-affinity IgE receptor (Fc epsilon RI): From physiology to pathology
15. Regulation of immune responses through inhibitory receptors
16. Fc-signalling in the modulation of immune responses by passive antibody
17. Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade
18. Cytotoxic antibodies trigger inflammation through Fc receptors
19. Fc receptors are required in passive and active immunity to melanoma
20. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors
21. Fc receptors for immunoglobulin G-a role in the pathogenesis of Guillain-Barre syndrome and multiple sclerosis
22. Identification of a soluble Fc gamma-binding molecule (annexin II) in human serum using a competitive ELISA
23. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG
24. Immunoglobulin G Fc-receptor (FcgammaR) IIA and IIIB polymorphisms related to disability in MS
25. Receptor-mediated phagocytosis of myelin by macrophages and microglia: Effect of opsonization and receptor blocking agents
26. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages
27. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules
28. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG
29. Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens
30. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice
31. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice
32. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis
33. In situ hybridization with digoxigenin-labeled probes: Sensitive and reliable detection method applied to myelinating rat brain
34. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG)
35. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines
36. Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis
37. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
38. Syk protein tyrosine kinase regulates Fc receptor gamma-chain-mediated transport to lysosomes
39. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages
40. Deletion of fcgamma receptor IIB renders H-2 (b) mice susceptible to collagen-induced arthritis
41. IgE-mediated suppression of primary antibody responses in vivo
42. No evidence for a role of FcgammaRIIB in suppression of in vivo antibody responses to erythrocytes by passively administered IgG
43. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
44. Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein
45. Bone marrow-derived elements in the central nervous system: An immunohistochemical and ultrastructural survey of rat chimeras
46. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages
47. The role of macrophages in demyelination
48. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats
49. Pathogenesis of tissue injury in MS lesions
50. Axonal pathology in multiple sclerosis: Relationship to neurologic disability
51. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
52. Identification of autoanfibodies associated with myelin damage in multiple sclerosis
53. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
54. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
55. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis
56. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
57. Normal polyclonal immunoglobulins (IVIg) inhibit microglial phagocytosis in vitro
58. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors
59. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins
60. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)
61. Inflammation in the nervous system. Basic mechanisms and immunological concepts
62. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization
63. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
64. Attenuation of experimental autoimmune demyelination in complement-deficient mice
65. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
66. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis